
Brian J. Davis
Examiner (ID: 8682, Phone: (571)272-0638 , Office: P/1672 )
| Most Active Art Unit | 1621 |
| Art Unit(s) | 1621, 1627, 1672, 1614, 1615, 1612 |
| Total Applications | 2900 |
| Issued Applications | 2335 |
| Pending Applications | 201 |
| Abandoned Applications | 384 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16711823
[patent_doc_number] => 20210078970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => PRODRUGS OF THE TYROSINE KINASE INHIBITOR FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/005852
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17005852
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/005852 | Prodrugs of the tyrosine kinase inhibitor for treating cancer | Aug 27, 2020 | Issued |
Array
(
[id] => 17874309
[patent_doc_number] => 11446301
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Quinoline analogs as phosphatidylinositol 3-kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/004734
[patent_app_country] => US
[patent_app_date] => 2020-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6416
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17004734
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/004734 | Quinoline analogs as phosphatidylinositol 3-kinase inhibitors | Aug 26, 2020 | Issued |
Array
(
[id] => 17322513
[patent_doc_number] => 11213499
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-01-04
[patent_title] => Use of 3,3'-diselenodipropionic acid (DSePA) as an anticancer agent
[patent_app_type] => utility
[patent_app_number] => 17/003420
[patent_app_country] => US
[patent_app_date] => 2020-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 4248
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17003420
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/003420 | Use of 3,3'-diselenodipropionic acid (DSePA) as an anticancer agent | Aug 25, 2020 | Issued |
Array
(
[id] => 16688226
[patent_doc_number] => 20210070702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => Amphiphilic Cyclohexylbenzene Compounds Derived from Alpha Olefins or Vinylidene Alpha Olefin Dimers
[patent_app_type] => utility
[patent_app_number] => 17/003475
[patent_app_country] => US
[patent_app_date] => 2020-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6282
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17003475
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/003475 | Amphiphilic cyclohexylbenzene compounds derived from alpha olefins or vinylidene alpha olefin dimers | Aug 25, 2020 | Issued |
Array
(
[id] => 16688298
[patent_doc_number] => 20210070774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => PENAM DERIVATIVES FOR TREATING BACTERIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/001764
[patent_app_country] => US
[patent_app_date] => 2020-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17001764
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/001764 | Penam derivatives for treating bacterial infections | Aug 24, 2020 | Issued |
Array
(
[id] => 20401230
[patent_doc_number] => 12491190
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Bile acid derivative, composition and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/637450
[patent_app_country] => US
[patent_app_date] => 2020-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 9
[patent_no_of_words] => 2291
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17637450
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/637450 | Bile acid derivative, composition and application thereof | Aug 23, 2020 | Issued |
Array
(
[id] => 16613607
[patent_doc_number] => 20210032260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => Beta-lactamase inhibitor and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/998577
[patent_app_country] => US
[patent_app_date] => 2020-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 542
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16998577
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/998577 | b-lactamase inhibitor and use thereof | Aug 19, 2020 | Issued |
Array
(
[id] => 16665082
[patent_doc_number] => 10934314
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-03-02
[patent_title] => Method for preparing organoboron derivative containing oxygen and aromatic ring as labeled precursor of dopamine positron emission tomography imaging agent
[patent_app_type] => utility
[patent_app_number] => 16/994860
[patent_app_country] => US
[patent_app_date] => 2020-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2472
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16994860
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/994860 | Method for preparing organoboron derivative containing oxygen and aromatic ring as labeled precursor of dopamine positron emission tomography imaging agent | Aug 16, 2020 | Issued |
Array
(
[id] => 16626734
[patent_doc_number] => 20210045387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => COMPOSITIONS AND METHODS TO INHIBIT ARTHROPOD HOST-SEEKING BEHAVIOR
[patent_app_type] => utility
[patent_app_number] => 16/993809
[patent_app_country] => US
[patent_app_date] => 2020-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16993809
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/993809 | COMPOSITIONS AND METHODS TO INHIBIT ARTHROPOD HOST-SEEKING BEHAVIOR | Aug 13, 2020 | Abandoned |
Array
(
[id] => 17414029
[patent_doc_number] => 20220048933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => METHOD FOR THE SYNTHESIS OF ASYMMETRIC POLYSULFIDES
[patent_app_type] => utility
[patent_app_number] => 16/993441
[patent_app_country] => US
[patent_app_date] => 2020-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1603
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16993441
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/993441 | Method for the synthesis of asymmetric polysulfides | Aug 13, 2020 | Issued |
Array
(
[id] => 16908957
[patent_doc_number] => 11040983
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-06-22
[patent_title] => Cocrystal of varenicline and oxalic acid, pharmaceutical composition thereof, and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/993439
[patent_app_country] => US
[patent_app_date] => 2020-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3735
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16993439
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/993439 | Cocrystal of varenicline and oxalic acid, pharmaceutical composition thereof, and methods of use thereof | Aug 13, 2020 | Issued |
Array
(
[id] => 16727757
[patent_doc_number] => 20210094904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => POSITION-SPECIFIC ASYMMETRIC DEUTERIUM ENRICHED CATECHOLAMINE DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/992199
[patent_app_country] => US
[patent_app_date] => 2020-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16992199
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/992199 | POSITION-SPECIFIC ASYMMETRIC DEUTERIUM ENRICHED CATECHOLAMINE DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS | Aug 12, 2020 | Abandoned |
Array
(
[id] => 20185861
[patent_doc_number] => 12396961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Compounds and compositions for intracellular delivery of agents
[patent_app_type] => utility
[patent_app_number] => 16/991196
[patent_app_country] => US
[patent_app_date] => 2020-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 20
[patent_no_of_words] => 87604
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16991196
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/991196 | Compounds and compositions for intracellular delivery of agents | Aug 11, 2020 | Issued |
Array
(
[id] => 16955192
[patent_doc_number] => 11059023
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-07-13
[patent_title] => Method for preparing acid-resistant Zr-MOF material with selective adsorption of hexavalent chromium
[patent_app_type] => utility
[patent_app_number] => 16/990017
[patent_app_country] => US
[patent_app_date] => 2020-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 2047
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16990017
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/990017 | Method for preparing acid-resistant Zr-MOF material with selective adsorption of hexavalent chromium | Aug 10, 2020 | Issued |
Array
(
[id] => 16734364
[patent_doc_number] => 10959985
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-03-30
[patent_title] => Pharmaceutical compositions including carvedilol and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 16/987443
[patent_app_country] => US
[patent_app_date] => 2020-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 19721
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16987443
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/987443 | Pharmaceutical compositions including carvedilol and methods of using the same | Aug 6, 2020 | Issued |
Array
(
[id] => 17044897
[patent_doc_number] => 11098065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => Preparation method of an energetic coordination compound with 5-methyltetrazole
[patent_app_type] => utility
[patent_app_number] => 16/985713
[patent_app_country] => US
[patent_app_date] => 2020-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 1985
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16985713
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/985713 | Preparation method of an energetic coordination compound with 5-methyltetrazole | Aug 4, 2020 | Issued |
Array
(
[id] => 16970433
[patent_doc_number] => 11066394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Solid forms of an HPK1 inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/985526
[patent_app_country] => US
[patent_app_date] => 2020-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 25171
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16985526
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/985526 | Solid forms of an HPK1 inhibitor | Aug 4, 2020 | Issued |
Array
(
[id] => 18171732
[patent_doc_number] => 11571424
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositions containing them
[patent_app_type] => utility
[patent_app_number] => 16/942094
[patent_app_country] => US
[patent_app_date] => 2020-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 23221
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16942094
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/942094 | Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositions containing them | Jul 28, 2020 | Issued |
Array
(
[id] => 16435663
[patent_doc_number] => 20200352988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => METHODS OF TREATING CHRONIC INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/942757
[patent_app_country] => US
[patent_app_date] => 2020-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18765
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16942757
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/942757 | Methods of treating chronic inflammatory diseases | Jul 28, 2020 | Issued |
Array
(
[id] => 18716492
[patent_doc_number] => 11793814
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Compositions and methods for treating, preventing or reversing age associated inflammation and disorders
[patent_app_type] => utility
[patent_app_number] => 16/934826
[patent_app_country] => US
[patent_app_date] => 2020-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 118
[patent_no_of_words] => 43000
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16934826
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/934826 | Compositions and methods for treating, preventing or reversing age associated inflammation and disorders | Jul 20, 2020 | Issued |